The Fed halted tightening and propelled equities to their fastest recovery ever following a bear market. This decision was made despite the lowest unemployment rate in 40 years. Does that make sense? Also, a possible deal with China.
The food fight between the President and the Fed Chair could result in too much easing, and the expansion of valuations beyond sustainable levels. The other food fight: leveraged loan issuers vs buyers. Issuers are winning this fight hands down due.
Michael looks at the midterms: GOP gains in the Senate, an historic loss in the House given economic and market conditions, and what it means for investors.
Michael discusses US-China trade war in context, the outlook for prescription drug price legislation, and an updated ideological scorecard for 2020 Presidential candidates.
Explores how institutional investors should reconfigure portfolio allocations/strategies in a world of low returns.
A close look at the Progressive Agenda, China’s deteriorating welcome mat in DC and US Tech IPOs.
Eye on the Market: The Verdict
Michael Cembalest analyzes the performance of over 6,700 domestic and international active equity managers, and discusses the challenges they face outperforming at a time of markets distorted by quantitative easing.
For the first time in 20 years, markets will have to survive without support from central banks.
Michael shares his thoughts on the US China trade war, Mexico tariffs and the US immigration policy.